Growing political headwinds threaten to dent US solar manufacturing and project deployment, despite a strong start to 2025.

(Reuters) -Cancer diagnostic firm Caris Life Sciences said on Monday it is targeting a valuation of up to $5.35 billion in ...

More gains are in store for stablecoin issuer Circle (NYSE:CRCL) following a strong IPO debut this past Thursday. After ...